Solène Clavreul, PhD, Myeloma Patients Europe, Brussels, Belgium, briefly discusses a round table session at the CAR-T Meeting 2024, which explored how to maximize cross-project synergy, stakeholder engagement, and the impact of European projects. Several projects aim to improve the access issues European patients may experience when needing CAR T-cell therapy, and this session allowed for details of the projects to be shared to foster collaboration and avoid duplicating work to minimize patient costs. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.